Huntington National Bank Raises Position in Henry Schein, Inc. (NASDAQ:HSIC)

Huntington National Bank grew its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 16.8% during the third quarter, Holdings Channel reports. The firm owned 1,515 shares of the company’s stock after purchasing an additional 218 shares during the period. Huntington National Bank’s holdings in Henry Schein were worth $110,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of HSIC. Vanguard Group Inc. lifted its stake in Henry Schein by 1.7% during the 1st quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock valued at $1,165,425,000 after acquiring an additional 260,537 shares in the last quarter. American Century Companies Inc. lifted its position in shares of Henry Schein by 3.1% during the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock valued at $351,543,000 after purchasing an additional 162,477 shares in the last quarter. Swedbank AB purchased a new position in Henry Schein during the first quarter worth about $215,998,000. Nuance Investments LLC grew its position in Henry Schein by 6.2% in the 2nd quarter. Nuance Investments LLC now owns 1,863,333 shares of the company’s stock worth $119,440,000 after purchasing an additional 108,143 shares in the last quarter. Finally, Burgundy Asset Management Ltd. increased its stake in Henry Schein by 1.0% in the 2nd quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company’s stock valued at $105,148,000 after buying an additional 16,476 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $68.76 on Monday. The firm has a market capitalization of $8.57 billion, a PE ratio of 28.30, a P/E/G ratio of 1.97 and a beta of 0.87. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The company has a 50-day moving average price of $70.30 and a two-hundred day moving average price of $69.57. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same period last year, the firm earned $1.32 EPS. Henry Schein’s revenue for the quarter was up .4% on a year-over-year basis. Equities analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on HSIC shares. Evercore ISI boosted their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. JPMorgan Chase & Co. cut their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. Finally, Robert W. Baird decreased their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $78.89.

Insider Activity

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This represents a 22.65 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.14% of the stock is owned by company insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.